New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Quick Hits: HPV Vaccine Approved to Prevent Cancer

The latest version of Merck’s human papilloma virus vaccine has a new official use.

According to the Centers for Disease Control and Prevention, head and neck cancer affects 13,500 Americans each year, and is the most common malignancy caused by HPV. A recent STAT News article noted that the disease can now be prevented with the same vaccine that prevents HPV. For the past decade, evidence has suggested this might be the case, but the FDA just made it official, granting accelerated approval for Merck’s Gardasil 9. 

The vaccine, which is recommended for males and females ages 9 to 45, prevents cervical, vulvar, vaginal, and anal cancer as well as genital warts. Cancers of the head and neck, especially those of the tonsils and throat, were left off the list until this month. The FDA approved the drug based on data related to preventing anogenital infection.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub